The Impact of Liver Metastasis on Anti-PD-1 Monoclonal Antibody Monotherapy in Advanced Melanoma: Analysis of Five Clinical Studies

Anti-programmed cell death protein 1 (PD-1) monoclonal antibody therapy is becoming a standard treatment for advanced melanoma that produces durable responses and prolonged survival, but the prognosis of patients with liver metastases is still unsatisfactory. Here, we analyzed five clinical studies...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Wang, Xuan, Ji, Qing, Yan, Xieqiao, Lian, Bin, Si, Lu, Chi, Zhihong, Sheng, Xinan, Kong, Yan, Mao, Lili, Bai, Xue, Tang, Bixia, Li, Siming, Zhou, Li, Cui, Chuanliang, Guo, Jun
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7552942/
https://ncbi.nlm.nih.gov/pubmed/33117684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.546604
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados